Health insurer CEO: ‘Make prior authorization illegal’ | Jakob Emerson | ResearchPod

Transcript: Health insurer CEO: ‘Make prior authorization illegal’

Alex: Welcome to another episode of ResearchPod. Today we're looking at new public prior authorization data — and the argument that the system may function less as a clinical filter than as a costly gatekeeping mechanism.

Sam: So the central question is whether prior authorization is actually screening out inappropriate care, or just creating friction?

Alex: That's the frame. And the key insight is that the overturn pattern matters more than the raw denial rate. If denials are routinely reversed on appeal, the initial decision looks less like careful utilization management and more like administrative drag — a first pass that fails its own review process.

Sam: And this is visible now because CMS is requiring plans to report denials and appeals publicly?

Alex: Right, at least for Medicare Advantage, Medicaid managed care, and ACA marketplace plans. That reporting creates a public audit trail: how often insurers say no, and how often they later walk that back.

Sam: But the numbers are incomplete. So what can you actually infer?

Alex: Only a partial picture. The load-bearing finding is that denial rates vary widely across plans, and when denials are appealed, many are overturned. That combination is hard to square with a system that's primarily screening out inappropriate care.

Sam: Why does the overturn rate carry more weight than the denial rate on its own?

Alex: Because the denial rate alone could still reflect legitimate triage. The overturn rate tells you how often the insurer's own review process rejects its first-pass decision. If a plan reverses itself frequently, the initial denial isn't doing much clinical sorting — it's imposing delay, paperwork, and provider labor before the claim reaches the outcome it should have reached earlier. The appeal is functioning as a correction layer for a bad first filter.

Sam: And the KFF analysis is where this pattern shows up empirically?

Alex: Yes. KFF's first-year analysis of the reported data found denial rates sitting in a fairly narrow band across major plan types, but appeals were often successful — and at least one insurer's overturned-denial share was especially high. The exact figures matter less than the structural pattern: the system is generating denials that don't survive scrutiny.

Sam: Which is why the administrative burden argument lands so hard.

Alex: Exactly. The policy brief cited here estimates that prior authorization consumes the equivalent of more than 99,000 full-time clinicians and costs tens of billions of dollars annually. That's the economic backbone of the critique. Even if some denials produce genuine savings, the process itself may be generating deadweight loss large enough to erase them.

Health insurer CEO: ‘Make prior authorization illegal’

Jakob Emerson

Sep 6, 2026·5:22·user_upload

Prior authorizationInsurance denial ratesAppeals and overturn ratesCMS reporting requirementsAdministrative burden in healthcare

Listen

5 min

Briefing

What question the piece addresses

The article asks whether prior authorization is a useful cost-control tool or an unnecessary barrier to care. It frames the debate around newly public insurer denial data, industry reform efforts, and a more radical proposal from some critics: abolish prior authorization altogether.

What evidence it uses

The piece draws on the first year of publicly reported prior authorization data for Medicare Advantage, Medicaid managed care, and ACA marketplace plans. It reports that insurers denied roughly 12% to 18% of prior authorization requests, and that many appealed denials were later overturned. The article also notes that denial rates vary across insurers and that the data are incomplete because they do not cover employer-sponsored insurance and do not reveal the specific services denied.

Main takeaway

The central message is that prior authorization appears to be both widespread and opaque, with enough denials and reversals to fuel arguments that the system is functioning as a blunt gatekeeping mechanism rather than a precise quality or cost-control tool. The article amplifies the view of Sidecar Health’s CEO, Patrick Quigley, who says the system creates waste by denying care and should be made illegal. It also contrasts that position with the insurance industry’s defense that prior authorization remains a necessary check on spending.

Why it matters

The piece matters because it shows how policy debate is shifting from incremental simplification toward more fundamental questions about whether prior authorization should exist at all. It also points to upcoming CMS changes that will make prior authorization more electronic and more transparent, which may reduce administrative friction even if the practice itself remains in place.

Key Terms and Definitions

Prior authorization — A process requiring insurer approval before certain services, drugs, or procedures can be covered.
Appeal overturn rate — The share of denied prior authorization requests that are later reversed after patients or clinicians challenge the decision.
Gold carding — A policy that exempts high-performing providers from prior authorization requirements because of their past approval patterns.
Non-network, cash-price insurer — An insurer model that lets members see any provider and pays fixed benefit amounts rather than using a traditional contracted network.
Corporate care veto — The advocacy term used here to describe prior authorization as a mechanism that lets insurers block care for financial reasons.
EHR-integrated prior authorization — A system that allows clinicians to submit requests and receive decisions directly through electronic health record software.

Health insurer CEO: ‘Make prior authorization illegal’: Research Paper Podcast